TRV045 is a novel, highly selective sphingosine-1-phosphate subtype 1 (S1P 1) receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain secondary to diabetic ...
The symptoms of type 2 diabetes can be hard to spot in the beginning, but there are certain warning signs that you should look out for, especially when it comes to your feet ...